TLDR
- Morgan Stanley downgraded Kering from “overweight” to “equal-weight,” reducing the price target to €320 from €330.
- Shares dropped more than 3% on Monday in response to the rating cut.
- The firm noted minimal upside remains after the stock’s impressive year-to-date performance, suggesting gains are “priced in.”
- Gucci, the company’s primary revenue driver, faces a projected 6.2% sales decline in Q1 2026 — a worse outlook than previously anticipated.
- The rating change arrives just before Kering’s Q1 2026 earnings announcement on April 14 and Capital Markets Day on April 16.
Shares of Kering declined sharply Monday after Morgan Stanley reversed course on the French luxury conglomerate, slashing its rating mere days before critical financial disclosures.
The investment bank shifted its stance from “overweight” to “equal-weight” while reducing its 12-to-18-month valuation target from €330 to €320. The announcement sent shares tumbling over 3%.
Morgan Stanley’s rationale centered on recent performance: Kering had significantly outperformed competitors including LVMH, Hermès, and Richemont by 300 to 1,700 basis points year-to-date. According to the firm, this surge has largely exhausted near-term upside potential.
“Our DCF implies 15% upside to the shares, which no longer translates into relative outperformance,” analysts stated in their research note.
The stock peaked at €320.50 on January 12 this year before tumbling approximately 16% through Monday’s session. A dramatic 10.90% spike on February 10 — the period’s largest single-day advance — was subsequently erased by consecutive declines of 5.04% and 6.35% on March 2 and 3.
Gucci Remains the Primary Challenge
Gucci continues to represent the biggest obstacle. Morgan Stanley’s revised forecast now anticipates a 6.2% contraction for the brand in Q1 2026, deteriorating from the previously estimated 5% decline. Looking ahead, Gucci revenues are projected at €5.95 billion for full-year 2026, climbing to €7.67 billion by 2028.
Analysts characterized the dynamic as “a classic case where improving buzz is running ahead of the hard numbers.” Their proprietary research across European retail channels revealed “early signs of improving brand buzz but little evidence yet of a meaningful commercial recovery.”
The tempered forecast also reflects softer first-quarter market intelligence and Kering’s vulnerability to Middle East geopolitical tensions, representing approximately 5% of consolidated revenues.
Critical Timing and Forward Outlook
The downgrade arrives at a pivotal juncture. Kering plans to release Q1 2026 financial results on April 14, immediately followed by its Capital Markets Day on April 16. These presentations will prove crucial in determining whether executive leadership’s turnaround narrative resonates with investors.
Morgan Stanley adjusted its 2028 earnings per share projection downward by 4% to €15.97, which nonetheless remains 15% above the Visible Alpha consensus of €13.80. At current levels, shares trade around 17 times forward earnings.
The firm anticipates group-wide revenues reaching €18.3 billion by 2028, representing approximately 25% growth from 2025’s €14.7 billion figure. Consolidated operating margins are forecast to expand from 12.5% in 2026 to 18.4% by 2028.
Morgan Stanley’s optimistic scenario values shares at €480, predicated on a Gucci renaissance and group margins expanding to 25.9% in 2028. The pessimistic case targets €175, assuming the brand’s new direction fails commercially. Current options market pricing suggests approximately 28.9% probability of shares exceeding €320 within twelve months, versus 17.1% odds of falling below €175.
Analysts identified two potential catalysts for upgrading their view: continued operational restructuring under CEO Luca de Meo, who assumed leadership in September 2025, and tangible proof of sustained commercial momentum at Gucci.
Notably, Morgan Stanley had previously upgraded Kering in October 2025, identifying it among their top European luxury picks while praising the sector’s “burst of creativity.” Monday’s action represents a complete reversal of that earlier endorsement.
